Our understanding of the spatiotemporal expression of Lrigs during mouse neural development is rudimentary.
Therefore, in situ hybridization was used to examine the expression of Lrig1, Lrig2, and Lrig3 in the mouse nervous system at different developmental stages. E14.5 coronal (A-I), E14.5 sagittal (J-L), E16.5 (see Figure 1) , and P9 coronal (M-R) mouse sections were analyzed. Partially overlapping but clearly distinct patterns of expression were detected for each of the three Lrig family members. Incubation of sections with Lrig1, Lrig2 or Lrig3 sense probes did not yield specific staining (not shown). CA, cornu amonis; CB, cerebellum; Cx, cortex; DG, dentate gyrus; EGL, external granule layer; FV, fourth ventricle; IGL, internal granule layer; LGE, lateral ganglionic eminence; HC, hippocampus; IC, inferior colliculus; LV, lateral ventricle; Mb, midbrain; ML, molecular layer; MO, medulla oblongata; OB, olfactory bulb; OE, olfactory epithelium; Po, pons; SC, superior colliculus; Th, thalamus; VZ, ventricular zone. Scale bars, 500 µm. coronal mouse brain sections. The anti-Lrig2 antibody is characterized in Figure S3 , anti-Lrig1 and anti-Lrig3 antibodies were as reported previously (Poulin et al., 2014 , Lindström et al., 2014 . Sections are counterstained with fluorescent Nissl (blue). Immunohistochemistry revealed strong Lrig1 expression in ventricular zones throughout the brain, including in the hippocampus (hip) (G). Lrig2 expression was strong and widespread, for example in the cortex (CX) (e.g. intermediate zone (IZ) and cortical plate (CP) (B, E)), septum (K), and anterior commissure (M). Immunohistochemistry for Lrig3 revealed only weak neural expression for this Lrig family member (C, F, I, L, O). AC, anterior commissure; DG, dentate gyrus; FIM, fimbria; LV, lateral ventricle; S, septum; STR, striatum; VZ, ventricular zone. Scale bars, 100 µm. 
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Neo-FN1-6 C. Anti-GFP pull-down on HEK293 cell lysates co-transfected with pcDNA3.1-Neogenin-GFP-Bio and GW1-Lrig-V5 truncation constructs revealed that the LRR and Ig-like domains of Lrig2 interact with Neogenin.
D.
Anti-V5 pull-down on HEK293 cell lysates co-transfected with GW1-Lrig2-FL-V5 and GW1-myc-Neogenin truncation constructs, revealed that both the FN1-6 and Ig-like domains of Neogenin interact with Lrig2.
E, F. Quantification of band intensities in experiments as shown in C and D, respectively. The ratio between Neo-GFP-Bio bait and (truncated) Lrig2-V5 (E) or Lrig2-V5 bait and (truncated) Myc-Neo (F) in respective IP samples in C and D was determined. To calculate the relative interaction, the ratio in IP samples was normalized to each corresponding input sample. Data are presented as means (of three independent experiments) ± S.E.M. 
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Graphs showing Neogenin, Lrig2 or ADAM17 levels as determined by quantitative PCR at 14 days after intravitreal injections of (combinations of) siRNAs or DNA (pCAG-Neogenin-GFP) in adult mice. Expression levels were normalized to internal GAPDH control. *P<0.05, **P<0.01, Student's t-test. Data are presented as means (of three independent experiments, n = 3 retinas per condition) ± S.E.M.
G. Quantitative analysis of regenerating axons following optic nerve injury extending at specific distances from the distal end of the crush site. pCAG-Neogenin-GFP or pCAG-GFP expression vector and CTB were injected in the eye and mice were sacrificed at day 14 post-injury. At least five sections per animal were quantified.
Overexpression of Neogenin-GFP significantly decreased optic nerve regeneration. n = 6 animals per condition. *P<0.05, Student's t-test. Data are presented as means ± S.E.M.
H. Streptavidin pull-down assays were performed on lysates of HEK293 cells co-expressing Lrig1-GFP and
NeogeninFL-GFP-Bio (NeoFL-GFP-Bio) or Bio-GFP and BirA. Proteins bound to streptavidin beads were analyzed by Western blotting using the indicated antibodies. Lrig1-GFP is precipitated in the NeoFL-GFP-Bio protein complexes (arrow head) and not in the Bio-GFP control complexes. PD, pull-down. List of gene symbols for proteins identified in a pull down experiment using Streptavidin-coated beads on lysates from HEK293 cells transfected with Lrig2-GFP-Bio and BirA. Listed proteins for the selected GO-categories were detected with a Mascott score of >40 and are unique for Lrig2-GFP-Bio precipitates. Non-specific proteins interacting with Bio-GFP were removed. Neogenin is in bold. Note: LRIG1 and LRIG3 were also identified as Lrig2-Bio-GFP interactors but are not assigned to any of the selected GO-categories.
Category
Proteins In the upper part, primers used to create in situ hybridization (ISH) probes for Lrig1, Lrig2 and Lrig3, and to detect Lrig2, Neogenin (Hagihara et al., 2011) and ADAM17 (van Roeyen et al. 2013) in quantitative PCR (q-PCR) are listed. The size of the resulting PCR product is indicated in base pairs (bp).
In the lower part, target site sequence in Lrig2 for shLrig2-A, -B, and -C, in Lrig3 for shLrig3-D, -E, and -F, and the corresponding rescue site containing synonymous point mutations for Lrig2-RS-A (in bold) are given. The target site sequence in Neogenin for shNeo and the rescue site sequence in Neo-RS, and the target site sequences in Lrig2 for siRNA#1 and #2 are listed as well. All sequences are from '5 to '3. For information on siRNAs please see ON-TARGET plus siRNA library (http://dharmacon.gelifesciences.com). 
Supplemental Experimental Procedures Animals and Tissue Treatment
All animal use and care were in accordance with institutional guidelines. C57BL/6 mice were obtained from Charles River. Timed-pregnant mice were killed by means of cervical dislocation. The morning on which a vaginal plug was detected was considered embryonic day 0.5 (E0.5). The day pups were born was defined as postnatal day (P)0. For in situ hybridization experiments, E14.5 and E16.5 embryos, and P9 heads were frozen in 2-methylbutane (Merck). For immunohistochemistry, E16.5 heads and adult eyes were collected in phosphate-buffered saline (PBS, pH 7.4) and fixed by immersion for 3 hours (hrs) in 4% paraformaldehyde (PFA) in PBS at 4°C. Tissue was washed in PBS, cryoprotected in 30% sucrose at 4°C and frozen in 2-methylbutane. Sections (16 µm) were cut on a cryostat, mounted on Superfrost Plus slides (Fisher Scientific), air-dried and stored desiccated at -80°C for in situ hybridization and at -20°C for immunohistochemistry.
In Situ Hybridization
Nonradioactive in situ hybridization was performed according to Pasterkamp et al. 1998 . In brief, probe sequences for Lrig2 (NM_001025067: nt 1149-1761) and Lrig3 (Genepaint.org: probe 43) were polymerase chain reaction (PCR)-amplified from cDNA, using primer sequences listed in the Table S2 . The probe sequence for Lrig1 (Genepaint.org: probe 90) was generated by reverse transcription-PCR (RT-PCR) on adult mouse whole brain RNA (primers listed in Table S2 ). In situ hybridization probes for RGMa and Neogenin were as described . Digoxigenin (DIG)-labeled RNA probes were generated by an RNA polymerase reaction using 10x DIG RNA labeling mix (ENZO). Tissue sections were post-fixed in 4% PFA in PBS (pH 7.4) for 20 minutes (min) at room temperature (RT). To enhance tissue penetration and decrease non-specific background staining, sections were acetylated with 0.25% acetic anhydride in 0.1 M triethanolamine and 0.06% HCl for 10 min at RT. Sections were pre-hybridized for 2 hrs at RT in hybridization buffer (50% formamide, 5x Denhardt's solution, 5x SSC, 250 µg/ml baker's yeast tRNA and 500 µg/ml sonicated salmon sperm DNA). Hybridization was performed for 15 hrs at 68°C, using 400 ng/ml denatured DIG-labeled probe diluted in hybridization buffer.
After hybridization, sections were first washed briefly in 2x SSC followed by incubation in 0.2x SCC for 2 hrs at 68°C. Sections were adjusted to RT in 0.2x SSC for 5 min. DIG-labeled RNA hybrids were detected with anti-DIG Fab fragments conjugated to AP (Boehringer) diluted in 1:2500 in TBS (pH 7.4) overnight at 4°C. Binding of AP-labeled antibody was visualized by incubating the sections in detection buffer (100 mM Tris-HCl, pH 9.5, 100 mM NaCl and 50 mM MgCl2) containing 240 µg/ml levamisole and nitroblue tetrazolium chloride/5-bromo-4-chloro-3-indolyl-phosphatase (NBT/BCIP, Roche) for 14 hrs at RT. Sections subjected to the entire in situ hybridization procedure, but with no probe or sense probe added, did not exhibit specific hybridization signals.
The specificity of the in situ hybridization procedure was also inferred from the clearly distinct gene expression patterns observed. Staining was visualized using a Zeiss Axioskop 2 microscope.
Immunohistochemistry
Sections were washed in PBS (pH 7.4), blocked in blocking buffer (PBS, 5% horse serum (Sigma-Aldrich), 1%
bovine serum albumin (BSA), 1% glycine, 0.1% lysine and 0.4% Triton) for 1 hr at RT, and incubated with primary antibodies in blocking buffer overnight at 4°C. Antibodies were used at the following dilutions; goat anti-Lrig1 antibody (1:50; R&D systems AF3688) (Poulin et al. 2014) , rabbit anti-Lrig2-C antibody (1 µg/ml) ( on 100 µg/ml poly-D-lysine (Sigma-Aldrich) and 40 µg/ml laminin (Invitrogen) coated, acid-washed coverslips in a humidified atmosphere with 5% CO2 at 37°C. Neurons were transfected with DNA constructs and siRNA (mouse Lrig2 or scrambled non-targeting control pool, ON-TARGETplus, Dharmacon) at DIV1 using Lipofectamine 2000 (Invitrogen) . In brief, 400 ng DNA and 40 pmol siRNA per well was mixed with 3 µl of Lipofectamine 2000 in 200 µl of NB, incubated for 30 min, and then added to the neurons in NB at 37°C in 5% CO2 for 45 min. Next, neurons were washed with NB, transferred to the original medium, and kept for 2 days at 37°C in 5% CO2.
Primary hippocampal cultures were prepared from E18 rat embryos. Cells were plated on coverslips coated with poly-L-lysine (30 µg/ml) and laminin (2 µg/ml) at a density of 100,000 cells/well. Hippocampal cultures were grown in NB supplemented with B27, 0.5 mM glutamine, 12.5 µM glutamate and penicillin/streptomycin (pen/strep). Hippocampal neurons were co-transfected with DNA constructs and siRNAs (rat Lrig2 or scrambled non-targeting control pool, ON-TARGETplus, Dharmacon) using Lipofectamine 2000 (Invitrogen) as described above at DIV1 (live experiments) or at DIV4 (fixed experiments).
Immunocytochemistry
Cells were fixed with 4% PFA for 15 min at RT and washed in PBS (pH 7.4). Cells were permeabilized and blocked in blocking buffer (PBS, 4% bovine serum albumin (BSA) and 0.1% Triton X-100) for 1 hr at RT. Cells were incubated with rabbit anti-Lrig2-C (0.5 µ/ml) in blocking buffer for 2 hrs at RT. Cells were washed in PBS and incubated with Alexa Fluor-labeled goat anti-rabbit secondary antibodies (1:500; Invitrogen) for 1 hr at RT. Dissociated E14.5 cortical neurons were fixed and incubated in blocking solution for 1 hr at RT and incubated with rabbit anti-Lrig2-C antibody (1 µg/ml) and goat anti-Neogenin antibody (1:400; AF1079, R&D systems) in blocking solution overnight at 4°C. The next day, cells were washed in PBS and incubated with the appropriate Alexa Fluor-labeled secondary antibodies (1:500; Invitrogen) for 1 hr at RT. Staining was visualized using a Zeiss Axioskop 2 microscope and an Olympus FluoView FV1000 confocal microscope.
Growth Cone Collapse Assay
Mouse P0 dissociated primary cortical neurons were transfected with 0,5 µg pCAG-GFP and 50 pmol siRNA (mouse Lrig2 or scrambled non-targeting control pool, ON-TARGETplus, Dharmacon) at DIV1 using Lipofectamine 2000 (Invitrogen) (for details on transfection see Dissociated Primary Neuron Cultures). After treatment with medium containing 2 µg/ml RGMa-His (R&D systems) or control medium for 30 min, cortical neurons were fixed with 4% PFA and 15% sucrose for 20 min at RT and washed in PBS (pH 7.4). The neurons were immunostained with anti-GFP and with Alexa-568-tagged phalloidin (1:500; Invitrogen) to visualize growth cones. Growth cone collapse was quantified for >100 neurons per condition for two separate experiments. Growth cones were considered collapsed when they lost their hand shaped-like protrusions and resembled an axon-like structure. Statistical analysis was performed using Student's t-test.
Plasmid Construction
A biotin-and GFP-tagged full-length human Lrig2 cDNA (pcDNA3.1-Lrig2FL-GFP-Bio) was generated by subcloning a GFP-biotin tag (Groen et al., 2013) C-terminal to the full-length Lrig2 coding sequence amplified from wild type Lrig2 cDNA (pCMV-hLrig2) in a pcDNA3.1(-)/myc-his (Invitrogen) vector backbone. Similarly, biotin-GFP tagged Neogenin cDNA was generated (pcDNA3.1-NeoFL-GFP-Bio) by amplification from fulllength mouse Neogenin cDNA (pCMVXL-6-Neogenin; a kind gift of Stephen Strittmatter, Yale School of Medicine). To generate pHLuorin-Neogenin full-length Neogenin was amplified and SacI/KpnI restriction sites were introduced, followed by cloning into the pHLuorin-C3 vector (a kind gift from Ruud Toonen, VU Amsterdam). The Neogenin intracellular domain (NeoICD; 1158-1492) was subcloned C-terminal to the GFP sequence of a modified pEGFP-C1 vector expressing a biotin-GFP fusion protein to generate a biotin-GFP-
NeoICD-expression vector (pEGFP-Bio-GFP-NeoICD). Full-length and truncated myc-tagged mouse Neogenin
constructs were created by subcloning fragments into the GW1-myc vector using AgeI/BglII restriction sites. A pCAG vector expressing full-length Neogenin-GFP was generated by ligation of the Neogenin-GFP-biotin fragment (isolated by PmeI restriction) from pcDNA3.1-NeoFL-GFP-Bio into the SmaI site of the pCAG-GFP vector. Full-length mouse Lrig2 and Lrig2 truncation mutants were amplified from pCDH-Lrig2 (a kind gift from Dennis Selkoe, Harvard Medical School) and subcloned into the GW1-myc vector using HindIII/BglII restriction sites. The myc-tag was replaced by cloning a V5 tag into the GW1-myc backbone, using SalI/EcoRI restriction sites, to generate a GW1-Lrig2-FL-V5 vector.
For RNA interference experiments, DNA fragments encoding short hairpin (sh) RNAs directed against mouse Lrig2, mouse Lrig3, or mouse Neogenin (sequences listed in TableS2) were cloned into pSuper, using BglII/HindIII restriction sites (Brummelkamp et al. 2002) . A pSuper vector expressing a scrambled, non-targeting shRNA (sequence listed in Table S2 ) was used as a control. A full-length Lrig2 rescue construct (GW1-Lrig2-RS-A-V5) insensitive to shLrig2-A was created by introducing non-coding point mutations into the GW1-Lrig2-FL-V5 vector. Similarly, a full-length Neogenin rescue construct (pcDNA3.1-myc-Neogenin-RS) was generated (see Table S2 for the mutated target sites). Primers containing the point mutations were used to amplify the construct, followed by DpnI digestion and transformation. The insertion of the mutation was confirmed by sequencing and loss-of-sensitivity to shLrig2-A and shNeo was shown by Western Blot.
For production of Fc-tagged RGMa, the extracellular domain of RGMa lacking the GPI link was cloned into a phLSec backbone vector ). pEFBOS-Sema4D-Flag was a kind gift from Atsushi Kumanogoh (Osaka University) (Kumanogoh et al. 2000) . NCAM1-GFP was as reported previously (Van Battum et al. 2014 ). The expression vector containing mouse ADAM17 (pcDNA3.1-ADAM17/TACE) was as reported previously (Okamura et al. 2011) .
Immunoprecipitation
Immunoprecipitation of biotin-tagged proteins was performed as described previously (Groen et al. 2013) . mM NaCl, 1% NP-40 and 10% glycerol) and precipitated proteins were eluted by boiling in NuPAGE LDS sample buffer containing 2.5% β-mercaptoethanol for 10 min at 70°C.
In-Gel Analysis
Pull-down samples were separated in a NuPAGE Novex 4-12% Bis-Tris gradient gel following the manufacturer´s description (Invitrogen) . For mass spectrometry analysis, proteins were visualized using GelCode Blue Stain Reagent (Pierce). Silver staining was used to detect differential protein bands. The gel was soaked twice in 50% methanol, followed by 10 min incubation in 5% methanol. After 3 rinses in water, the gel was incubated in 10 µM dithiothreitol (DTT) for 20 min, followed by 0.1% (w/v) AgNO3 for 20 min. The gel was washed once in water and twice in developer solution (3% (w/v) Na2CO3 and 0.02% (w/v) formaldehyde). The gel was incubated in the developer solution until protein bands appeared. The staining reaction was stopped by adding 5% (w/v) citric acid.
Gel Digestion and Nanoflow LC-MS/MS Analysis
1D SDS-PAGE gel lanes were cut into 2-mm slices using an automatic gel slicer and subjected to in-gel reduction with DTT, alkylation with iodoacetamide and digestion with trypsin (Promega, sequencing grade), essentially as described previously (Wilm and Mann 1996) . Nanoflow LC-MS/MS was performed on a CapLC system (Waters, Mass spectra were acquired in continuum mode; fragmentation of the peptides was performed in data-dependent mode. Peak lists were automatically created from raw data files using the Protein Lynx Global Server software (version 2.0). The background subtraction threshold for noise reduction was set to 35% (background polynomial 5). Smoothing (Savitzky-Golay) was performed (number of interactions: 1, smoothing window: 2 channels).
Deisotoping and centroiding settings were: minimum peak width: 4 channels, centroid top: 80%, TOF resolution: 5000, NP multiplier: 1. Mascot search algorithm (version 2.0, MatrixScience) was used for searching against the NCBInr database that was available on the MatrixScience server. The peptide tolerance was typically set to 150 ppm and the fragment ion tolerance was set to 0.2 Da. A maximum number of 1 missed cleavage by trypsin was allowed and carbamidomethylated cysteine and oxidized methionine were set as fixed and variable modifications, respectively.
Western Blotting
Cells were collected in ice-cold PBS (pH 7.4) with a cell scraper and centrifuged at 1000 rpm for 5 min in a precooled centrifuge at 4°C. The cell pellet was resuspended in ice-cold lysis buffer (20 mM Tris-HCl, pH 8, 150 mM KCl, 1% Triton X-100 and Complete protease inhibitor cocktail (Roche)), incubated on ice for 10 min, followed by centrifugation at 14,000 rpm for 10 min at 4°C. The supernatant was collected, NuPAGE LDS sample buffer (Invitrogen) containing 2.5% β-mercaptoethanol was added, and samples were boiled for 5 min at 95°C. Proteins were separated on an 8% SDS-PAGE gel and transferred onto nitrocellulose membrane (Hybond-C Extra;
Amersham). Membranes were incubated in blocking buffer (TBS, 0.05% (v/v) Tween 20 and 5% milk powder)
for 30 min at RT, followed by incubation with primary antibody in blocking buffer overnight at 4°C. Antibodies (single-letter amino acid code) in the cytosolic tail of mouse Lrig3 was developed and affinity-purified as previously described for LRIG1 (Nilsson et al. 2003 ) (5 µg/ml). Membranes were incubated with appropriate peroxidase conjugated secondary antibodies in blocking buffer for two hrs at RT, followed by incubation with SuperSignal West Dura Extended Duration Substrate (Pierce) and exposure to ECL films (Pierce). Films were digitized and quantified by measuring background corrected band intensities using ImageJ. Intensities were normalized to the appropriate control band for each film. Every experiment was repeated and quantified at least three times.
Biotinylation of Surface Proteins and Internalization Assay
N1E-115 cells transfected with pSuper-shScr or pSuper-shLrig2 were cultured for 4 days. Surface proteins were biotinylated by incubating cells on ice for 30 min with 1 mg/ml EZ-Link™ Sulfo-NHS-Biotin (for surface protein analysis) or EZ-Link™ Sulfo-NHS-SS-Biotin (cleavable biotin group for internalization analysis), both from Thermo Scientific, in Wash Buffer (PBS with 1 mM CaCl2 and 0.5 mM MgCl2). Unbound biotin was quenched by washing with 100 mM glycine in Wash Buffer. For surface analysis, cells were subsequently lysed and processed for pull-down with streptavidin-coated beads, as described above. For internalization analysis, washed cells were returned to the incubator for 30 min to allow for internalization of biotinylated surface proteins. Biotin groups were removed from remaining surface proteins by incubation with cleaving buffer (50 mM glutathione in 75 mM NaCl, 10 mM EDTA, pH 7.5) for 2x15min on ice. Cells were then washed with Wash Buffer, lysed and processed for pull-down with streptavidin-coated beads as described. Pull-down and input samples were analyzed by western blot and digitized band intensities were quantified using ImageJ. The ratio between Neogenin in input samples and in pull-down samples was calculated and normalized to siScr control condition.
Membrane Fractionation
P0 mouse brains were used to prepare subcellular membrane fractions as described previously (Van Battum et al., 2014) . In brief, three volumes of fractionation buffer (0.25 M sucrose, 1 mM EDTA, 5 mM NaCl, 10 mM KCl, protease inhibitor cocktail (Sigma) and 10 mM Tris-HCl pH7.5) were added, followed by homogenization using a tissue grinder (Wheaton). Nuclei were removed by centrifuging at 800 g for 3 min at 4 °C. The supernatant was centrifuged at 9,200 g for 10 min and the supernatant containing both the cytosolic and membrane fractions was collected. These fractions were separated by centrifugation at 165,000 g for 1 h, resulting in a cytosol-enriched supernatant and a plasma membrane-enriched pellet. The pellet was washed and resuspended in sucrose buffer and used for Western blot analysis. The efficiency of the fractionation procedure was confirmed by Western blot using antibodies against cytosolic tubulin and actin and membrane proteins Neogenin, Lrig2 and Sema6a (data not shown). Membrane fractions were split in three and immunoprecipitated using antibodies against Neogenin, Sema6a or goat IgG control, as described. IP samples and input were analyzed by Western blot.
ELISA
Enzyme-linked immunosorbent assays (ELISAs) were performed as described previously (Okamura et al., 2011) .
In brief, mouse Neogenin-ECD-Fc (0.005-2.0 µg/ml; R&D systems) diluted in 0.1% BSA/PBS was added to 96-well ELISA microplates (Thermo Fisher Scientific) coated with 0.5 µg/ml BSA or 0.5 µg/ml recombinant ADAM17 (R&D systems). To examine the effect of Lrig2, Neogenin-ECD-Fc was pre-incubated with 5.0 µg/ml BSA or 5.0 µg/ml Lrig2-ECD purified from HEK293 cells in PBS, before addition to ADAM17-coated ELISA plates. Two hours after incubation at RT, plates were washed, diluted, and anti-Neogenin (1:1000; R&D systems) or anti-Fc antibody (1:1000; Sigma) was added. HRP-conjugated secondary antibodies, a substrate reagent pack, and stop solutions (R&D systems) were used for detection. The absorbance at 450 nm was measured. Values were statistically analyzed using one-way ANOVA, followed by Scheffe's multiple comparison test.
Cell Culture and Transfection
COS-7, HEK293 and N1E-115 cells were maintained in high glucose Dulbecco's modified Eagle's medium (DMEM; Gibco, Invitrogen). CHO and stable RGMa-expressing CHO (CHO-RGMa) cell lines were as described previously (Hata et al. 2006) . CHO cells were cultured in Ham's F12 Nutrient Mixture (Gibco, Invitrogen) . COS-7, HEK293 and CHO cell culture media were supplemented with 10% (v/v) heat-inactivated (FBS; Lonza, BioWhittaker), 2 mM L-glutamine (PAA), and 1x pen/strep (PAA). N1E-115 cell culture medium was supplemented with 2% FBS and 1x pen/strep. CHO cells were cultured in the presence of 300 µg/ml hygromycin B (Roche). All cells were cultured in a humidified atmosphere with 5% CO2 at 37°C. COS-7 cells and HEK293 cells were transfected using polyethylenimine (PEI; Polysciences). N1E-115 cells were transfected using Lipofectamine 2000 (Invitrogen) .
RGMa Protein Production
For alkaline phosphatase ( RGMa-Fc protein was neutralized through addition of 10 mM Tris-HCl (pH 9.5). RGMa-Fc was dialyzed against PBS using centrifugal filter units (Amicon Ultra, 0.5 ml, 10K, Ultracel-10K membrane; Millipore). Protein concentration was determined by in-gel analysis of GelCode Blue Stain Reagent (Pierce) stained SDS-PAGE gels using a BSA standard curve. As a control, human IgG Fc fragment (Calbiochem) was used.
AP Cell Binding
COS-7 cells were transfected with wild type mouse Neogenin (pCMVXL-6-Neogenin) or GW1-Lrig2-V5. At DIV2, the culture medium was replaced by HBHA buffer (20 mM HEPES, pH 7.0, 1x Hank's balanced salt solution (HBSS; GIBCO, Invitrogen) and 0.5 mg/ml BSA) for 15 min at RT. Subsequently, cells were incubated with medium containing AP or RGMa-AP for 75 min, while gently rotating at RT, followed by 4 washes in HBHA buffer. Then, cells were incubated in fixative (20 mM HEPES, pH 7, 60% (v/v) acetone and 3.7% formaldehyde) for 30 seconds, followed by 2 washes in HBHA. HBHA was replaced by HBS (20 mM HEPES, pH 7.0, 150 mM NaCl) and endogenous phosphatase activity was heat-inactivated by incubation at 65°C for 90 min. Cells were equilibrated in detection buffer (100 mM Tris-HCl, pH 9.5, 100 mM NaCl and 5 mM MgCl2) and bound AP- Where indicated, 10 µM TAPI-1 (Millipore) dissolved in DMSO or DMSO alone was added 24 hrs before fixation.
After 4 days, cells were fixed with 4% PFA for 15 min at RT and washed in PBS (pH 7.4). Cells were permeabilized and blocked in blocking solution (PBS, 4% BSA and 0.1% Triton X-100) for 1 hr at RT and incubated with rabbit anti-GFP (1:3,000; A11122; Invitrogen) and mouse anti-β-III-Tubulin (1:5,000; T8660, Sigma) in blocking solution overnight at 4°C. The next day, cultures were washed in PBS and incubated with Alexa Fluor-594 goat anti-mouse and Alexa Fluor-488 goat anti-rabbit (1:750; Invitrogen) for 1 hr at RT. Images were taken using a Cellomics ArrayScan VTI HCS Reader (Thermo Scientific) and the length of the longest neurite was measured using NeuronJ. Three separate wells per condition were analyzed and >75 neurites per well were measured. Data were statistically analyzed by two-way ANOVA and represented as means ±S.E.M.
RhoA Pull-down Assay
Primary dissociated cortical neurons were prepared from the cortex of embryonic day 18 (E18) mice. Cells were gently dissociated after digestion with 0.25% trypsin (Gibco/Invitrogen, Paisley, UK) and DNase1 (Takara, Shiga, Japan) at 37°C for 15 min. Cells were washed and resuspended in mouse neuron nucleofector solution (Lonza Cologne AG, Cologne, Germany) to a final concentration of 5 x 10 6 cells/100 µl. 500 pmol of siRNA was added to the cell-nucleofector solution complex, gently mixed and transferred into a cuvette, followed by nucleofection using the nucleofector program O-05. Immediately after electroporation, 500 µl of DMEM/F12 containing 10%
FBS was added to the cells, and the cell suspension was transferred into the poly-L-lysine-coated dishes. The medium was replaced with fresh DMEM/F12 containing B27 after 3 hrs, and the cells were incubated for an additional 72 hrs. The cells were treated with or without 2 µg/ml RGMa (R&D systems) for 15 min, and subjected to the Rho pulldown assay.
The Rho pulldown assay was modified from a previously described protocol (Ren & Schwartz 2000) .
Cells were lysed in lysis buffer containing 50 mM HEPES (pH 7.5), 1% Nonidet P-40, 150 mM NaCl, 30 mM MgCl2, 5% glycerol, 1 mM Na3VO4, 10 mM NaF, 1 mM DTT, 10 µg/ml leupeptin, and 10 µg/ml aprotinin, followed by centrifugation at 4°C at 15,000 rpm for 10 min. To collect active Rho protein, supernatants were incubated with 50 µg of GST-tagged Rho-binding domain (RBD) of rhotekin beads at 4 °C for 45 min. The beads were washed four times with lysis buffer and subjected to SDS-PAGE followed by western blotting using antiRhoA antibody. Whole cell lysates were also subjected to Western blotting for total RhoA. RhoA activation was assessed by comparing the band intensities of active RhoA bands with those of total RhoA in each lane using Multi
Gauge software (Fuji Film Corporation, Tokyo, Japan). Results are shown as fold increase relative to control values. Data are shown as the means ± S.E.M. of four independent experiments. Statistical analyses were performed using one-way ANOVA, followed by Tukey-Kramer's test.
In Utero Electroporation
Pregnant C57Bl/6 mice at E14.5 were deeply anaesthetized using isoflurane (induction: 3-4%, surgery 1.5-2%) and injected with 0.05 mg/kg buprenorfin hydrochloride in saline, after which the abdominal cavity was opened.
The uterus containing embryos was carefully exposed and the lateral ventricles of the embryo's were injected with (combinations of) shRNAs, siRNAs and DNA vectors together with pCAG-GFP dissolved in 0,05% Fast Green using glass micro-pipettes (Harvard Apparatus). Motor cortices were targeted by electroporation with an ECM 830
Electro-Square-Porator (Harvard Apparatus) set to five unipolar pulses of 50ms at 30V (950ms interval) using a platinum tweezer electrode holding the head (negative poles) and a third gold-plated Genepaddle electrode (positive pole) on top of the head (Fisher Scientific). Embryos were placed back into the abdomen, abdominal muscles and skin were sutured separately and mother mice awakened by releasing them from isoflurane. Embryos were collected at E16.5 and heads were fixed in 4% PFA and submerged in 30% sucrose. 20 µm cryosections were made and sections were processed for immunohistochemistry as described above. Z-stack acquisitions were taken using conventional confocal microscopy using a LSM700 (Zeiss). Migration of GFP-positive cells was analyzed as follows: using Adobe Photoshop, consistent rectangles divided in 8 equal square bins were placed on top of the image, so that bin 1 starts at the ventricle border of the tissue and bin 8 ends at the pial surface. Cells in each bin were counted and divided by the total amount of cells in the rectangle. The average of at least two rectangles of each image was used for comparison. Mann-Withney-U tests were used to statistically compare migration between conditions.
Optic Nerve Injury
siRNA targeting mouse Neogenin and a scrambled control siRNA were obtained from Sigma-Aldrich (St Louis, MO, USA), as described previously (Hagihara et al. 2011) . siRNAs targeting mouse Lrig2 are shown in the Table   below . siRNAs targeting mouse ADAM17 were obtained from Dharmacon (ON-TARGETplus siRNA pool). 3-week-old C57BL/6J mice were obtained from Charles River Laboratories. In vivo gene transfection of pCAG-GFP (mock) or pCAG-GFP-Neogenin was performed as described previously (Jiang et al. 2009 ). Optic nerve injury was performed as previously described (Fujita et al. 2011) . The left optic nerve was crushed with fine forceps for 10 sec approximately 1 mm posterior of the optic disc. 3 µl of a solution containing 1.5-2.0 µg of siRNA and/or 2 µl of DNA-Lipofectamine2000 complexes was injected intravitreally immediately following injury and on day 7
post-axotomy. At least 6 mice were used for each group. To visualize optic nerve axons, 1 µl of a solution containing cholera toxin β subunit (CTB) conjugated to Alexa Fluor-555 (2 µg/µl, Invitrogen) was injected intravitreally with a glass needle 12 days after the injury. On day 14 post-axotomy, mice were perfused with 4%
PFA. The eye cups with the nerve segment were post-fixed, and immersed in 15-30% sucrose overnight at 4°C.
Tissues were embedded in Tissue-Tek. Serial cross-sections (16 µm) were prepared using a cryostat and collected on MAS-coated glass slides (Matsunami, Osaka, Japan). CTB-labeled axons were visualized using DP Controller software (version 3.1.1.267; Olympus) on a microscope (BX51; Olympus) equipped with a camera (DP71; Olympus). Axonal regeneration was quantified by counting the number of CTB-labeled fibers extending 0.2, 0.5, and 1.0 mm from the distal end of the lesion site in 5 sections. The cross-sectional width of the optic nerve was measured at the point at which the measurements were taken and was used to calculate the number of axons per millimeter of nerve width. The number of axons per millimeter was then averaged over the 5 sections. ∑ad, the total number of axons extending distance d in a nerve having a radius of r, was estimated by summing all the sections having a thickness t (16 µm): ∑ad = πr 2 x [average axons / mm] / t. Statistical analysis were performed using Student's t-test.
Quantitative RT-PCR
Total RNA was extracted from retinas by Trizol (Invitrogen) . Gene specific quantitative RT-PCR was performed on 10 ng RNA per reaction in a 384 wells plate in triplicate using SYBR green RT-PCR kit (Qiagen) on a 7300
Fast Real-Time PCR system (Applied Biosystems). To control for (genomic DNA) contamination, samples with no template (water) and no reverse transcriptase (without enzyme mix) were run simultaneously for each RNA sample and each primer set. Primers for Neogenin and GAPDH were as described (Hagihara et al., 2011) , primers for Lrig2 and ADAM17 are listed in Table below . Ratios between GAPDH and Neogenin, Lrig2 or ADAM17
were calculated to determine knockdown efficiency. RNA samples obtained from three retinas per condition were statistically analyzed using Student's t-test and shown as means ±S.E.M.
Cell Surface Labeling and Internalization Assay
Two days after transfection, coverslips with dissociated cortical mouse neurons were incubated on ice with antiNeogenin antibody (1:200; AF1079, R&D) in conditioned medium for 20 min. Coverslips were returned to warm conditioned medium and incubated for 10 min in a humidified atmosphere with 5% CO2 at 37°C.
DNA vectors used for transfection were pCAG-GFP and pCAG-Neogenin-GFP. siScr, siLrig2 and siADAM17
ON-TARGETplus siRNA was obtained from Dharmacon. For cell surface staining, coverslips were washed in warm NB medium and fixed in PBS with 4% PFA and 4% sucrose (4% PFA/suc) for 8 min at RT. For staining of
